DE69320078T2 - Peritonealdialyselösungen die mindestens ein Dipeptid enthalten - Google Patents

Peritonealdialyselösungen die mindestens ein Dipeptid enthalten

Info

Publication number
DE69320078T2
DE69320078T2 DE69320078T DE69320078T DE69320078T2 DE 69320078 T2 DE69320078 T2 DE 69320078T2 DE 69320078 T DE69320078 T DE 69320078T DE 69320078 T DE69320078 T DE 69320078T DE 69320078 T2 DE69320078 T2 DE 69320078T2
Authority
DE
Germany
Prior art keywords
peritoneal
peritoneal dialysis
dipeptide
solution
solutions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69320078T
Other languages
English (en)
Other versions
DE69320078D1 (de
Inventor
Andrzej Breborowicz
Dimitrios G Oreopulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of DE69320078D1 publication Critical patent/DE69320078D1/de
Application granted granted Critical
Publication of DE69320078T2 publication Critical patent/DE69320078T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69320078T 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten Expired - Fee Related DE69320078T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83072192A 1992-02-04 1992-02-04

Publications (2)

Publication Number Publication Date
DE69320078D1 DE69320078D1 (de) 1998-09-10
DE69320078T2 true DE69320078T2 (de) 1999-03-25

Family

ID=25257564

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69320078T Expired - Fee Related DE69320078T2 (de) 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
DE69332959T Expired - Fee Related DE69332959T2 (de) 1992-02-04 1993-02-04 Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69332959T Expired - Fee Related DE69332959T2 (de) 1992-02-04 1993-02-04 Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen

Country Status (8)

Country Link
US (2) US5597805A (de)
EP (2) EP0804931B1 (de)
JP (1) JP3262620B2 (de)
AT (2) ATE239503T1 (de)
DE (2) DE69320078T2 (de)
DK (1) DK0555087T3 (de)
ES (1) ES2121941T3 (de)
GR (1) GR3027714T3 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.
ATE226433T1 (de) * 1992-12-22 2002-11-15 Baxter Int Verbesserte aminosaureloesungen zur behandlung bei peritonealer dialyse
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
EP1009452A4 (de) 1997-08-07 2004-03-31 Ajay Gupta Wasserlösliche vitamine und nährstoffe enthaltende dialyselösung
DE69929550T8 (de) 1998-05-21 2006-12-28 Nipro Corp. Albumin enthaltende Lösung für die Peritonealdialyse
AU4553700A (en) 1999-04-26 2000-11-10 Pe Chou Chang Substitution infusion fluid and citrate anticoagulation
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6627164B1 (en) 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
EP1466602A4 (de) * 2001-12-25 2006-03-01 Ajinomoto Kk Organfibroseinhibitoren
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
KR101480585B1 (ko) 2007-10-01 2015-01-08 세이가가쿠 고교 가부시키가이샤 신규 저분자화 콘드로이틴황산 및 그 용도
US8841262B2 (en) * 2009-03-31 2014-09-23 Cci Corporation Agent for inhibiting peritoneal membrane thickening
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
WO2015142624A1 (en) 2014-03-17 2015-09-24 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
CA2991781C (en) 2015-09-16 2020-01-14 Stephen A. Merchant Cartridges useful in cleaning dialysis solutions
EP3352586A4 (de) 2015-09-21 2019-05-15 The Board Of Trustees Of The Leland Stanford Junior University Ernährungsbehandlung bei krebserkrankungen
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
EP3723772A4 (de) * 2017-12-11 2021-09-08 Filtricine, Inc. Zusammensetzungen, verfahren, kits und systeme zur krebsbehandlung und stoffwechselinterventionstherapie
GB202202728D0 (en) * 2022-02-28 2022-04-13 Invizius Ltd Peritoneal fluid composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4339433A (en) * 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) * 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
US4976683A (en) * 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
DE3812525C1 (de) * 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
JPH02196724A (ja) * 1989-01-26 1990-08-03 Terumo Corp 腹膜透析液
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.

Also Published As

Publication number Publication date
GR3027714T3 (en) 1998-11-30
DE69320078D1 (de) 1998-09-10
EP0555087A1 (de) 1993-08-11
ATE239503T1 (de) 2003-05-15
JP3262620B2 (ja) 2002-03-04
EP0804931B1 (de) 2003-05-07
US5955450A (en) 1999-09-21
DE69332959T2 (de) 2004-05-13
EP0804931A2 (de) 1997-11-05
ATE169223T1 (de) 1998-08-15
EP0555087B1 (de) 1998-08-05
US5597805A (en) 1997-01-28
DE69332959D1 (de) 2003-06-12
DK0555087T3 (da) 1999-05-03
EP0804931A3 (de) 2001-04-11
ES2121941T3 (es) 1998-12-16
JPH05345021A (ja) 1993-12-27

Similar Documents

Publication Publication Date Title
DE69320078D1 (de) Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
FR2639233B1 (fr) Agent d'hygiene en hemodialyse
US5284470A (en) Wearable, portable, light-weight artificial kidney
AU6951087A (en) Pump block for interfacing irradiation chamber to photoactivation patient treatment system
WO1992003202A3 (en) Medical drug formulation and delivery system
CA2250919A1 (en) Photopheresis treatment of leukocytes
DE3888120D1 (de) Integrierte Behandlungseinheit für extrakorporalen Blutkreislauf.
FR2680318B1 (fr) Rein artificiel et procede de commande.
ATE63694T1 (de) Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung.
IE790952L (en) Acyl-carnitine solutions for haemodialysis
AU6950887A (en) Disposable temperature probe for photoactivation patient treatment system
IE821162L (en) Dialysis solution
NO940506D0 (no) Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater
DE68907402T2 (de) Durchflussregler für Medizinlösungen oder für Bluttransfusionsgeräte.
ES2078332T3 (es) Disolucion de celulosa en agua y oxido-n de metilmorfolina-n.
DE69624914T2 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
US4881562A (en) Heart valve and xenograft washing system
ATE251473T1 (de) Hämodialysegerät
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
SE9000192L (sv) System respektive saett foer maetning av halten av en substans i en loesning eller dispersion av densamma, varvid substansen utgoeres av ett aemne som aer icke elektriskt ledande eller svagt elektriskt ledande
ES2069499A1 (es) Procedimiento de envasado de compuestos y concentrados para utilizar en el tratamiento de la dialisis y hemodialisis.
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee